Jacobs Marc D, Black James, Futer Olga, Swenson Lora, Hare Brian, Fleming Mark, Saxena Kumkum
Vertex Pharmaceuticals Incorporated, Cambridge, Massachusetts 02139, USA.
J Biol Chem. 2005 Apr 8;280(14):13728-34. doi: 10.1074/jbc.M413155200. Epub 2005 Jan 17.
Pim-1 is an oncogene-encoded serine/threonine kinase primarily expressed in hematopoietic and germ cell lines. Pim-1 kinase was originally identified in Maloney murine leukemia virus-induced T-cell lymphomas and is associated with multiple cellular functions such as proliferation, survival, differentiation, apoptosis, and tumorigenesis (Wang, Z., Bhattacharya, N., Weaver, M., Petersen, K., Meyer, M., Gapter, L., and Magnuson, N. S. (2001) J. Vet. Sci. 2, 167-179). The crystal structures of Pim-1 complexed with staurosporine and adenosine were determined. Although a typical two-domain serine/threonine protein kinase fold is observed, the inter-domain hinge region is unusual in both sequence and conformation; a two-residue insertion causes the hinge to bulge away from the ATP-binding pocket, and a proline residue in the hinge removes a conserved main chain hydrogen bond donor. Without this hydrogen bond, van der Waals interactions with the hinge serve to position the ligand. The hinge region of Pim-1 resembles that of phosphatidylinositol 3-kinase more closely than it does other protein kinases. Although the phosphatidylinositol 3-kinase inhibitor LY294002 also inhibits Pim-1, the structure of the LY294002.Pim-1 complex reveals a new binding mode that may be general for Ser/Thr kinases.
Pim-1是一种癌基因编码的丝氨酸/苏氨酸激酶,主要在造血细胞系和生殖细胞系中表达。Pim-1激酶最初是在莫洛尼鼠白血病病毒诱导的T细胞淋巴瘤中被鉴定出来的,它与多种细胞功能相关,如增殖、存活、分化、凋亡和肿瘤发生(Wang, Z., Bhattacharya, N., Weaver, M., Petersen, K., Meyer, M., Gapter, L., and Magnuson, N. S. (2001) J. Vet. Sci. 2, 167 - 179)。已确定了与星形孢菌素和腺苷复合的Pim-1的晶体结构。尽管观察到典型的双结构域丝氨酸/苏氨酸蛋白激酶折叠,但结构域间的铰链区在序列和构象上都不寻常;两个残基的插入导致铰链从ATP结合口袋凸出,铰链中的一个脯氨酸残基消除了一个保守的主链氢键供体。没有这个氢键,与铰链的范德华相互作用有助于定位配体。Pim-1的铰链区与磷脂酰肌醇3激酶的铰链区比与其他蛋白激酶的铰链区更相似。尽管磷脂酰肌醇3激酶抑制剂LY294002也抑制Pim-1,但LY294002.Pim-1复合物的结构揭示了一种可能对丝氨酸/苏氨酸激酶普遍适用的新结合模式。